Effects of cannabis oil on people with Autism Specter Disorder
DOI:
https://doi.org/10.56294/ri202538Keywords:
Cannabis Oil, Autism Spectrum Disorder, Treatment, CannabidiolAbstract
Introduction: Autism Spectrum Disorder (ASD) is characterized by deficits in communication and social interaction. Despite lacking a definitive cure, multidisciplinary therapeutic and pharmacological approaches are employed to mitigate their symptoms. However, the potential side effects of conventional treatments drive the search for alternatives such as cannabis derivatives for symptom relief.
Objective: to analyze the eficacia of cannabis derivatives in the treatment of ASD.
Method: a search for information was carried out in the databases and search engines Pubmed, Embase, Google Scholar and SciELO. The inclusion criteria are oriented towards observational studies and clinical trials analyzing the effects of cannabis derivatives in individuals diagnosed with autism spectrum disorders.
Results: the treatment of autism using cannabis oil derivatives has emerged as a contemporary research topic in the academic literature. Despite that several studies, including systematic reviews and double-blind clinical trials, have examined the benefits of cannabidiol (CBD) in individuals diagnosed with ASD.
Conclusion: it is feasible to infer, based on the scientific papers reviewed in this study, that treatment of Autism Spectrum Disorder (ASD) with cannabis derivatives could be beneficial. However, the current evidence is limited, indicating the need for further research in this area
References
1. Mimura Paula, Ferreira Lisiane, Pereira Carla «Canabinoides no tratamento do autismo e epilepsia infantil» BrJP. São Paulo. 2023;6.
2. Alves GDS, Fockink JC, Marinho AM de S. Uso do Canabidiol no Transtorno do Espectro Autista, uma revisão integrativa. Braz. J. Hea. Rev. 2023; 6(3):12073-88. https://doi.org/10.34119/bjhrv6n3-288
3. Clea Marinho LM, Moraes Valença M, Eduardo Machado C, Edvany de Melo Pereira M, Kempter Brant P. Uso da Cannabis medicinal e autismo. JMM. 2020; 2(1):5-14. https://doi.org/10.37085/jmmv2.n1.2020.pp.5-14
4. Garrabé de Lara J. El autismo. Historia y clasificaciones. Salud Mental 2012;35:257-261. https://www.scielo.org.mx/pdf/sm/v35n3/v35n3a10.pdf
5. Engler GP, da Silva GAF, Torres TM, Priscilla D, Lopez AGP, da Silva M da CS, Morais MJ de D, Leitão FNC. O uso de Cannabis no tratamento do Transtorno do Espectro do Autismo – revisão sistemática. Braz. J. Hea. Rev. 2024; 7(1):1301-15. https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/66334
6. Duvall SW, Lindly O, Zuckerman K, Msall ME, Weddle M. Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders. Pediatrics. 2019; 143(2):e20180558. https://doi.org/10.1542/peds.2018-0558
7. Pretzsch CM, Voinescu B, Mendez MA, et al. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD). Journal of Psychopharmacology. 2019;33(9):1141-1148. doi:10.1177/0269881119858306
8. Echeburúa E, Salaberría K, Cruz-Sáez M. Contributions and limitations of DSM-5 from Clinical Psychology. Terapia psicológica. 2014; 32(1):65-74. https://dx.doi.org/10.4067/S0718-48082014000100007
9. Noa R, Iso H, Titti L, Giorgio M, Elyad M. D, Aharon M E. Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report. Frontiers in Pharmacology. 2022; 13https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.979403
10. Hacohen M, Stolar OE, Berkovitch M. Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study. Transl Psychiatry. 2022; 12:375. https://doi.org/10.1038/s41398-022-02104-8
11. Pretzsch CM, Voinescu B, Lythgoe D. Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy. Transl Psychiatry. 2019; 9:313. https://doi.org/10.1038/s41398-019-0654-8
12. Morante M, Morante M. Historias íntimas del cannabis medicinal. Editorial Paidós.
13. Leinow L, Birnbaum J. CBD el cannabis medicinal. Editorial Sirio.
14. Albarracín L, Baldeón E, Sangronis E, Petruschina A, Reyes F. L-Glutamato: un aminoácido clave para las funciones sensoriales y metabólicas» Archivos Latinoamericanos de nutrición. 2016; 66(2)
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Rayane Larissa Lopes Maia, Patricia Susana Salguero (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.